Janus Henderson Group PLC Purchases 30,057 Shares of Waters Corporation (WAT)

Janus Henderson Group PLC boosted its position in Waters Corporation (NYSE:WAT) by 1.6% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,959,850 shares of the medical instruments supplier’s stock after purchasing an additional 30,057 shares during the quarter. Janus Henderson Group PLC owned about 2.46% of Waters worth $351,832,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Oppenheimer Asset Management Inc. boosted its stake in Waters by 0.4% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock valued at $105,000 after purchasing an additional 2 shares during the period. ETF Managers Group LLC bought a new stake in Waters in the 2nd quarter valued at $106,000. Intellectus Partners LLC boosted its stake in Waters by 4.9% in the 2nd quarter. Intellectus Partners LLC now owns 667 shares of the medical instruments supplier’s stock valued at $123,000 after purchasing an additional 31 shares during the period. First Manhattan Co. bought a new stake in Waters in the 2nd quarter valued at $130,000. Finally, Edmond DE Rothschild Holding S.A. bought a new stake in Waters in the 2nd quarter valued at $160,000. Institutional investors and hedge funds own 92.29% of the company’s stock.

Waters Corporation (NYSE:WAT) traded up $2.82 during trading hours on Friday, hitting $199.29. The stock had a trading volume of 327,928 shares, compared to its average volume of 383,533. The company has a market cap of $15,625.85, a P/E ratio of 27.29, a price-to-earnings-growth ratio of 2.85 and a beta of 0.82. The company has a current ratio of 6.16, a quick ratio of 5.71 and a debt-to-equity ratio of 0.66. Waters Corporation has a 1 year low of $133.71 and a 1 year high of $201.95.

Waters (NYSE:WAT) last released its earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.03. Waters had a return on equity of 23.61% and a net margin of 24.34%. The firm had revenue of $565.58 million during the quarter, compared to the consensus estimate of $555.25 million. During the same period in the prior year, the company posted $1.57 EPS. The company’s revenue was up 7.4% compared to the same quarter last year. analysts expect that Waters Corporation will post 7.42 EPS for the current fiscal year.

In other news, SVP Elizabeth B. Rae sold 12,000 shares of the business’s stock in a transaction on Friday, November 3rd. The stock was sold at an average price of $197.95, for a total transaction of $2,375,400.00. Following the completion of the transaction, the senior vice president now owns 18,129 shares of the company’s stock, valued at approximately $3,588,635.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director William J. Miller sold 3,500 shares of the business’s stock in a transaction on Tuesday, December 5th. The stock was sold at an average price of $194.94, for a total value of $682,290.00. Following the transaction, the director now directly owns 25,849 shares of the company’s stock, valued at approximately $5,039,004.06. The disclosure for this sale can be found here. Insiders have sold a total of 45,913 shares of company stock valued at $9,084,685 in the last three months. 5.07% of the stock is owned by insiders.

WAT has been the subject of several recent research reports. BidaskClub upgraded Waters from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, August 16th. Jefferies Group reiterated a “hold” rating and set a $175.00 target price on shares of Waters in a research report on Thursday, August 31st. Goldman Sachs Group assumed coverage on Waters in a research report on Tuesday, September 26th. They set a “hold” rating and a $180.00 target price for the company. Morgan Stanley reiterated an “underweight” rating and set a $192.00 target price (up from $183.00) on shares of Waters in a research report on Friday, October 6th. Finally, Cleveland Research downgraded Waters from a “buy” rating to a “neutral” rating in a research report on Monday, October 9th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $193.62.

WARNING: This piece was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at https://stocknewstimes.com/2017/12/09/janus-henderson-group-plc-purchases-30057-shares-of-waters-corporation-wat.html.

Waters Company Profile

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply